A specialty pharmaceutical company, Shire Human Genetic Therapies has a worldwide sales and marketing infrastructure with a portfolio of products and its own direct marketing capability in the United States, Canada, England, Ireland, France, Germany, Italy and Spain. Its product line includes Agrylin, Calcichew, Carbatrol, Dynepo, Equetro, Fosrenol, Soloraze and Vaniqa. The company also covers other pharmaceutical markets indirectly through regional distributors. Its interest in the Pacific Rim is managed through Shire's regional office based in Singapore. Shire Human Genetic Therapies has a location in Cambridge, Mass.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.